前沿论文｜CELL INTELLIGENCE

Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL).

PubMed 2024/08/05 发表Curr Treat Options OncolQ1 · IF 5.8（JCR 2025）

48.8分

★★★☆☆

站内排序·非疗效

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.

PubMed 2024/02/13 发表Mol Ther OncolQ1 · IF 8.5（JCR 2025）

48.0分

★★★☆☆

站内排序·非疗效

Recent advances in monoclonal antibody development for treatment of B-cell acute lymphoblastic leukemia.

PubMed 2025/06/02 发表Leuk LymphomaQ3 · IF 2.1（JCR 2025）

37.3分

★★☆☆☆

站内排序·非疗效

Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis.

PubMed 2025/04/08 发表Transfus Med RevQ2 · IF 3（JCR 2025）

36.1分

★★☆☆☆

站内排序·非疗效

Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer.

PubMed 2023/08/11 发表Arch Immunol Ther Exp (Warsz)Q3 · IF 3.2（JCR 2025）

31.6分

★☆☆☆☆

站内排序·非疗效

前沿论文 5